Pharmachal Health Group is focused on research and development of pharmaceutical products. The Company has developed a range of human and veterinary preparations, including a breakthrough, patented, lignocaine-based, mini-emulsion spray for cut and wound treatment, "NOPAYNE*". Pharmachal is stepping up NOPAYNE for TGA registration and launch in 2022. *Nopayne is currently not-for-sale, nor approved for commercial sale. It has not been registered with the Therapeutic Goods Administration. It has, however, been used extensively in humanitarian and compounding environments.
Pharmachal Health Group is focused on research and development of pharmaceutical products. The Company has developed a range of human and veterinary preparations, including a breakthrough, patented, lignocaine-based, mini-emulsion spray for cut and wound treatment, "NOPAYNE*". Pharmachal is stepping up NOPAYNE for TGA registration and launch in 2022. *Nopayne is currently not-for-sale, nor approved for commercial sale. It has not been registered with the Therapeutic Goods Administration. It has, however, been used extensively in humanitarian and compounding environments.
Company Information
- Industry
- Pharmaceuticals
- Company Type
- Privately Held
- Founded
- 2015
- Employee Range
- 1-10
- Revenue Range
- Not available
Location
- Address
- 191 Balaclava Road Victoria Caulfield North
- City
- Melbourne
- Region
- Victoria
- Postal Code
- 3161
- Country
- Australia